Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4521852
Max Phase: Preclinical
Molecular Formula: C19H16N2O3S
Molecular Weight: 352.42
Molecule Type: Unknown
Associated Items:
ID: ALA4521852
Max Phase: Preclinical
Molecular Formula: C19H16N2O3S
Molecular Weight: 352.42
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=S(=O)(N/N=C(\c1ccccc1)c1ccc(O)cc1)c1ccccc1
Standard InChI: InChI=1S/C19H16N2O3S/c22-17-13-11-16(12-14-17)19(15-7-3-1-4-8-15)20-21-25(23,24)18-9-5-2-6-10-18/h1-14,21-22H/b20-19+
Standard InChI Key: CTMRZUKFSUFWCE-FMQUCBEESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 352.42 | Molecular Weight (Monoisotopic): 352.0882 | AlogP: 3.12 | #Rotatable Bonds: 5 |
Polar Surface Area: 78.76 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.94 | CX Basic pKa: 0.25 | CX LogP: 4.16 | CX LogD: 4.15 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.55 | Np Likeness Score: -0.69 |
1. Arshia, Begum F, Almandil NB, Lodhi MA, Khan KM, Hameed A, Perveen S.. (2019) Synthesis and urease inhibitory potential of benzophenone sulfonamide hybrid in vitro and in silico., 27 (6): [PMID:30738655] [10.1016/j.bmc.2019.01.043] |
Source(1):